These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10843191)

  • 1. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.
    Ajjan RA; Kemp EH; Waterman EA; Watson PF; Endo T; Onaya T; Weetman AP
    J Clin Endocrinol Metab; 2000 May; 85(5):2020-7. PubMed ID: 10843191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low frequency of autoantibodies to the human Na(+)/I(-) symporter in patients with autoimmune thyroid disease.
    Seissler J; Wagner S; Schott M; Lettmann M; Feldkamp J; Scherbaum WA; Morgenthaler NG
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4630-4. PubMed ID: 11134119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells.
    Tonacchera M; Agretti P; Ceccarini G; Lenza R; Refetoff S; Santini F; Pinchera A; Chiovato L; Vitti P
    Eur J Endocrinol; 2001 Jun; 144(6):611-8. PubMed ID: 11375795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of antigenic domains on the human sodium-iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroid disease.
    Kemp EH; Waterman EA; Ajjan RA; Smith KA; Watson PF; Ludgate ME; Weetman AP
    Clin Exp Immunol; 2001 Jun; 124(3):377-85. PubMed ID: 11472397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rarity of anti- Na+/I- symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid diseases (AITD).
    Chin HS; Chin DK; Morgenthaler NG; Vassart G; Costagliola S
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3937-40. PubMed ID: 11061560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modulation of the human sodium iodide symporter activity by Graves' disease sera.
    Ajjan RA; Findlay C; Metcalfe RA; Watson PF; Crisp M; Ludgate M; Weetman AP
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1217-21. PubMed ID: 9543144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity involving the human sodium/iodide symporter: fact or fiction?
    Heufelder AE; Joba W; Morgenthaler NG
    Exp Clin Endocrinol Diabetes; 2001; 109(1):35-40. PubMed ID: 11573137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibody against Na+/I- symporter in the sera of patients with autoimmune thyroid disease.
    Endo T; Kogai T; Nakazato M; Saito T; Kaneshige M; Onaya T
    Biochem Biophys Res Commun; 1996 Jul; 224(1):92-5. PubMed ID: 8694839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sodium iodide symporter is unlikely to be a thyroid/breast shared antigen.
    Muller I; Zhang L; Giani C; Dayan CM; Ludgate ME; Grennan-Jones F
    J Endocrinol Invest; 2016 Mar; 39(3):323-31. PubMed ID: 26253711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low frequency of pendrin autoantibodies detected using a radioligand binding assay in patients with autoimmune thyroid disease.
    Kemp EH; Sandhu HK; Watson PF; Weetman AP
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E309-13. PubMed ID: 23322815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the sodium iodide symporter in human kidney.
    Spitzweg C; Dutton CM; Castro MR; Bergert ER; Goellner JR; Heufelder AE; Morris JC
    Kidney Int; 2001 Mar; 59(3):1013-23. PubMed ID: 11231356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoantibody against Na+/I- symporter (NaIS)].
    Zeki K
    Nihon Rinsho; 1999 Aug; 57(8):1824-8. PubMed ID: 10483259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
    Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
    Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG; Ho SC; Minich WB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody against thyroid iodide transporter in the sera from patients with Hashimoto's thyroiditis possesses iodide transport inhibitory activity.
    Endo T; Kaneshige M; Nakazato M; Kogai T; Saito T; Onaya T
    Biochem Biophys Res Commun; 1996 Nov; 228(1):199-202. PubMed ID: 8912659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases.
    Joba W; Spitzweg C; Schriever K; Heufelder AE
    Thyroid; 1999 May; 9(5):455-66. PubMed ID: 10365677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of immunoglobulin G from patients with autoimmune thyroid disease to rat sodium-iodide symporter peptides: evidence for the iodide transporter as an autoantigen.
    Morris JC; Bergert ER; Bryant WP
    Thyroid; 1997 Aug; 7(4):527-34. PubMed ID: 9292938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease.
    Kemp EH; Ridgway JN; Smith KA; Watson PF; Weetman AP
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):291-9. PubMed ID: 10971445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-natrium/iodide symporter antibodies and other anti-thyroid antibodies in children with Turner's syndrome.
    Kucharska AM; Czarnocka B; Demkow U
    Adv Exp Med Biol; 2013; 756():131-8. PubMed ID: 22836628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2).
    Kemp EH; Gawkrodger DJ; Watson PF; Weetman AP
    Clin Exp Immunol; 1997 Sep; 109(3):495-500. PubMed ID: 9328128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.